ArticleCrohn's & colitis 3602023

Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Karin Cerna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.